ORF3a binds to host heme oxygenase HMOX1,329 which plays an essential role in anti-inflammatory effects via the NLRPS pathway.330–332 Treatment with compounds that inhibit the interaction between ORF3a and HMOX1 is an effective strategy for the treatment of COVID-19. This evidence concerns the gene HMOX1 and COVID-19.